The effect of conagenin (CNG) on myelosuppression induced by antitumor agents was investigated. The daily administration of CNGprevented reduction in the number of platelets (PLT) observed in peripheral blood of mice given mitomycin C (lO mg/kg) but did not prevent reduction in the number of leukocytes (WBC). The effect on PLT was also confirmed in mice given cyclophosphamide (lOOmg/kg). In mice given repeated doses of 5-fluorouracil (lOmg/kg), CNG prevented the reduction of PLT as well as WBCand maintained them at normal levels. CNG prevented reduction of the production of interleukin-2, 3 and 6 in cultured supernatants of spleen cells taken from mice given 5-fluorouracil.
macrophage colony-stimulating factor (GM-CSF) has been applied to restore leukocytes (WBC)1^, there are, except for some cytokines, no agents to restore platelets (PLT). The reduction in PLT seen with cancer chemotherapy can be fatal. Although cytokines like interleukin (IL)-12'4), IL-35'6), IL-64'7~11} and stem cell factor (SCF)12~15) can restore PLT, systemic administration of those cytokines can result in severe toxicity. Weset out to find a low molecular weight immunomodulator produced by microorganisms which stimulates the production ofWBCand PLTby induction ofcytokines16~21). Wefound that conagenin (CNG) prevents reduction of PLT in peripheral blood of mice given antitumor agents22).
CNG, an immunomodulator which binds exclusively to T cells activated by concanavalin A or cytokines, and augments production of lymphokines and T cell proliferation23'24*, was found in metabolites of Streptomyces roseosporus (Fig. 1) .
Wereport here the effect of CNGon prevention reduction of WBC and PLTin mice given antitumor agents.
Materials and Methods
Mice CDFi and C57BL/6 mice (5-6 weeks old, female) were purchased from Charles River Japan Inc. (Kanagawa, Japan) and were maintained under specific pathogen-free conditions at 23 ±2°C and 55 ± 5% humidity. They were employed for experiments at 6 to 7 weeks of age. Each experimental group consisted of 6 to 8mice. Produced by: Streptomyces roseosporus Mice were given CNGwith or without antitumor agents in schedules indicated in the figures. Peripheral blood was collected by puncture of retro-orbital venous plexus and the numberof WBC and PLTwas counted by a Coulter counter (Japan Scientific Instruments Co. Ltd., Tokyo, Japan).
Assessment of Lymphokine Production by Spleen Cells and Bone Marrow Cells
The effect of CNGon lymphokine production by lymphoid cells of mice was assessed as follows: CNGat 5mg/kg was administered ip on days 0 to 15 starting on the day given antitumor agents, 5-Fu at lOOmg/kgwas administered ip to C57BL/6miceon days 0, 4 and 8. Spleen cells and bone marrow cells of the femur were prepared from treated mice and l ml of each cell preparation at 5 x 106cells/ml in RPMI1640 (Nissui Seiyaku Co. Ltd., Tokyo, Japan) containing 10% heat inactivated fetal calf serum was plated, then incubated at 37°C in 5%CO2for 1 hour. Non-adherent cells in the plate were collected and each preparation at 1 x 107 cells/ml was incubated in RPMI1640 supplemented 10% heat inactivated fetal calf serum, 50 fXM2-mercaptoethanol, non essential amino acids, 1 fiM sodium pyruvate, 50 units/ml penicillin and 50/zg/ml streptomycin at 37°C in 5% CO2for 3 days. After incubation, the cultured supernatants were collected, and interleukin(IL)-2, IL-3 or IL-6 levels in the supernatants were determined by ELISA. ELISA kit for IL-2 was purchased from Becton Dickinson Labware (Bed ford, U.S.A.) and for IL-3 and IL-6 were from Endogen Inc (Boston, U.S.A.).
Statistical Analysis
Results are shown as the mean+standard deviation. The statistical significance of the data was analyzed by Student's /-test.
Results
Effect of CNGon Restoration of WBCand PLT in Mice Given Antitumor Agents, MMC, CY and 5-Fu The effect of CNGon restoration the number of WBCand PLTin peripheral blood of mice given antitumor agents was investigated.
CDFXmice were given lOmg/kg of MMConce and 5mg/kg of CNGdaily for 28 days and the number of WBCand PLT was monitored. Four days after the administration MMC significantly reduced the WBCcounts which recovered by day 8 (Fig. 2a) . CNGprevented the reduction on day 4. On the other hand, the number of PLT was not affected at day 4 but markedly reduced in 80% by MMCalone from days 8 to 24 and the reduction was prevented by the administration of CNG (Fig. 2b) .
The effect of CNGon PLTwas confirmed in mice given repeated doses of CY. CDFXmice were given lOOmg/kg of CY, every other day for 7 times and 5mg/kg of CNGdaily for 16 days beginning the day of first CY administration, and the number of WBCand PLT in peripheral blood were monitored. In this model, CNGcould not prevent the reduction of WBC (Fig. 3a) . The number of PLTwas reduced within 4 days and continued low up to day 16. Although CNGcould not prevent the reduction seen on day 4, it restored the number ofPLT on day 8 and this effect was observed up to day 16 (Fig. 3b) .
The effect of CNGin mice given 5-Fu was investigated. C57BL/6 mice were given lOOmg/kg of 5-Fu CNG(5mg/kg) was administered ip on days 0 to 27 and MMC(lOmg/kg) was administered ip on day 0 to CDFi mice. Each group consisted of 6 mice. CNG(5mg/kg) was administered ip on days 0 to 1 5 and CY (100 mg/kg) was administered ip every other days for 7 times starting at day 0 to CDFXmice. Each group consisted of8 mice. * P<0.05 and *** P<0.001 in comparison with CYalone.
on days 0, 4 and 8 and 5mg/kg ofCNG daily for 28 days. As shown in Fig. 4 , the number ofWBCas well as PLT was reduced by 5-Fu from days 4 to 16, whereas these reductions were prevented by CNG and kept at normal levels up to day 28.
Lymphokine Production in Cultures of Spleen and Bone Marrow Cells Taken from Mice Given CNGwith or without 5-Fu The effect of CNGon lymphokine production in cultures of spleen and bone marrowcells taken from mice given CNGwith or without 5-Fu was investigated. The lymphokine levels which are responsible for hematopoiesis in cultured supernatants of non-adherent cells from spleen and bone marrowcells taken from mice were monitored. As shown in Fig. 5a , IL-2 was increased in mice given CNGalone in days 4 to 16 and was reduced by 5-Fu alone in days 4 to 12. The reduction in lymphokine levels was prevented by CNG administration.
Although IL-3 production was reduced by CNGalone on days 4 to 12, it was augmented on day 16. CNG(5mg/kg) was administered ip on days 0 to 27 and 5-Fu (lOmg/kg) was administered ip on days 0, 4 and 8 to C57BL/6 mice. Each group consisted of 6 mice. *P<0.05, **P<0.01 and ***P<0.001 in comparison with 5-Fu alone. In mice given 5-Fu, it was reduced in days 4 to 16 and the reduction was prevented by CNGsignificantly (Fig. 5b) . Production of IL-2 and IL-3 in cultured supernatants of bone marrow cells was less than 1 unit/ml and less than lO pg/ml respectively.
Production of IL-6 in cultures of spleen and bone marrowcells is shown in Fig. 6 . In spleen cells, CNGtreatment reduced IL-6 levels on days 8 and 12 and the reduction was recovered on day 16. The administration of 5-Fu reduced it markedly in days 4 to 16 whereas CNGslightly prevented the reduction.
In bone marrow cells, CNGdid not show marked change of IL-6 production in days 4 to 16. The administration of 5-Fu augmented IL-6 production on day 4 and day 8 in maximumand the augmentation was observed in combined with CNGon day 4 in maximumand day 12. It was normalized on day 16 by combined treatments.
Discussion
CNGwas found as an immunomodulatorwhich stimulates activated T cells to proliferate and to enhance lymphokine production but does not stimulate macrophages24). It is known that hematopoiesis is mediated by a variety of lymphokines. Except by some cytokines, there are no agents known to stimulate PLT production. In this context, the effect ofCNGon PLT and WBCproduction in mice given antitumor agents were investigated. As shown in
Figs. 2 to 4, CNGprevented PLT reduction soon after administration of antitumor agents. It should be noted that the daily administration of CNG immediately after start of the administration of antitumor agents improved the nadir in reduction of PLT. It has been reported that cytokines such as G-CSF, IL-1, IL-6 and SCF can stimulate to increase the number of PLT in peripheral blood and those cytokines only promote the rebound of PLT reduction induced by antitumor agents but do not improve the nadir in reduction3'4'9'11'15*. In the case of CNG,as it improved the nadir and maintained the number of PLTat almost normal level. Then the action of CNGmaybe different from cytokines. CNGrestored the leukopenia induced by MMCand 5-Fu. CNGseems to be more responsible for PLT modulation than for WBC.We tested CNGwith G-CSFon reductions of PLTand WBCinduced by cyclophosphamide and found that CNGdid not affect the effect of G-CSF in improving the number of WBC,and it did maintain the number of PLT at normal levels. It can be considered that the effect of CNGon hematopoiesis is due to stimulation of lymphokine production by T cells in hematopoietic organs. Therefore, it is possible that CNGmay stimulate the production of lymphokines like IL-3 and IL-6 which are responsible for PLT production but not production of cytokines like G-CSF or GM-CSF.As reported previously, it was shown that CNG suppresses macrophage function in tumor bearing mice and inhibits IL-1 production25). The mechanism of action on macrophagesis not knownyet. Lymphokineproduction in cultures of spleen cells as a peripheral lymphoid organ and bone marrow cells as a primary lymphoid organ of mice given CNGwith or without 5-Fu were monitored (Figs. 5 and 6), because the administration of CNGdid not influence lymphokine levels in serum. Results indicate that CNGaugmented lymphokine production by spleen cells but not IL-6 production by bone marrow cells and it was effective in preventing the reduction induced by 5-Fu for lymphokine production. It is of note that 5-Fu enhanced IL-6 production by bone marrow cells but not by spleen cells. The mechanism of 5-Fu on enhancement of IL-6 production is not clear yet. However, it was reported that the proliferation of bone marrowcells is maintained for a week in high rate after the administration of 5-Fu26), although the number of WBCand PLT in peripheral blood were reduced2'9'21'26). It is likely that to restore the reduced cells by 5-Fu, the production of multipotent hematopoietic cytokines like IL-6 could be augmented to produce a variety of progenitor cells in bone marrow. From results reported here, it can be concluded that CNGprevents reduction of PLT induced by antitumor agents through modulation of lymphokine production. It will be reported that CNGenhances production of CFU-Megdepending upon Thy-1 positive cells and IL-6 and SCF in vitro and in vivo21). It has been found that lethal toxicity of antitumor agents is reduced by CNG,and the therapeutic indices of these substance with CNGare increased28*. As CNGis a low molecular weight and low toxicity, it OCT. 1994 mayhave usefulness in cancer chemotherapy and hematopoiesis dysfunctions, especially for diseases in which PLT are reduced. 
